|
FKBP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
6.31716901011714E-14 |
| Normal-vs-Stage3 |
2.26110000000057E-05 |
| Normal-vs-Stage4 |
9.254400E-01 |
| Stage1-vs-Stage2 |
3.454400E-01 |
| Stage1-vs-Stage3 |
2.456300E-02 |
| Stage1-vs-Stage4 |
2.065900E-02 |
| Stage2-vs-Stage3 |
1.876090E-02 |
| Stage2-vs-Stage4 |
1.292060E-02 |
| Stage3-vs-Stage4 |
9.377600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.06100017660538E-10 |
| Normal-vs-Asian |
4.619000E-01 |
| Caucasian-vs-AfricanAmerican |
4.726600E-01 |
| Caucasian-vs-Asian |
2.826400E-01 |
| AfricanAmerican-vs-Asian |
1.662400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
8.10795874883752E-13 |
| Male-vs-Female |
3.224800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.06119582407882E-13 |
| Normal-vs-Extreme_Weight |
1.62847513252018E-12 |
| Normal-vs-Obese |
1.80855330711438E-13 |
| Normal-vs-Extreme_Obese |
3.37800010186129E-10 |
| Normal_Weight-vs-Extreme_Weight |
9.000800E-01 |
| Normal_Weight-vs-Obese |
7.629600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.581600E-01 |
| Extreme_Weight-vs-Obese |
8.495600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.891200E-01 |
| Obese-vs-Extreme_Obese |
3.163600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.144300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.763000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.817900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.278500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.187040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.030600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.471000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.608200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.43249999640105E-08 |
| Normal-VS-KIRP CIMP |
9.623900E-02 |
| Normal-VS-Unclassified PRCC |
5.75059999619043E-10 |
| Type1 PRCC-VS-Type2 PRCC |
2.300400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.93994999999614E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.596000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.699600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.228000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.276000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70852221259565E-12 |
| Normal-vs-N1 |
1.791200E-01 |
| Normal-vs-N2 |
4.180400E-01 |
| N0-vs-N1 |
5.477600E-03 |
| N0-vs-N2 |
1.552440E-02 |
| N1-vs-N2 |
8.363000E-01 |
|
|
